Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Flowcharts compounds

This flowchart summarizes the method for using combustion analysis to determine the empirical formula of a compound that contains no elements other than C, H, and O. [Pg.165]

The flowchart lets us predict whether a salt is soluble or insoluble. For example, will Cu (0H)2 dissolve in water The compound does not contain NH4 or a Group 1 cation, nor does it contain any anion that confers solubility. Because Cu (0H)2 does not appear among the exceptions (Table 4-1 f. it is insoluble. Example further illustrates the solubility flowchart and net ionic equations. [Pg.228]

According to the flowchart, salts of chloride and sulfate are soluble. Therefore, no precipitate will form unless one of these compounds is included among the exceptions listed in Table 4A - Barium sulfate is one of these exceptions, so it is an insoluble salt. [Pg.229]

Figure 5.1 Compound evaluation flowchart for postscreening characterization of lead compounds. Figure 5.1 Compound evaluation flowchart for postscreening characterization of lead compounds.
Determination of the IC50 is a preliminary evaluation of the relative affinity of different compounds for a target enzyme. To evaluate affinity properly, however, one must first define the mechanism of inhibition of the target enzyme by each compound. The next step in the lead evaluation flowchart (Figure 5.1) is to determine if the inhibition caused by a compound is rapidly reversible, slowly reversible, or irreversible. This information will help the investigator understand whether or not the inhibition reaction can be treated as a reversible equilibrium, and thus decide on the best measure of true affinity for a particular compound. [Pg.125]

A general flowchart is presented in Fig. 13.5B that we followed for identifying and sorting inhibitors of translation. Shown below is an in vitro translation protocol tailored for ten 96-well assay plates (800 compounds), which can be scaled up or down as required. Negative and positive controls are present in wells A1 to D1 and El to HI, respectively. Compounds are added to wells A2 to Hll. Column 12 is left blank and could be used for additional controls, if desired. [Pg.319]

Figure 1. Flowchart for calculating critical loads (left) or steady-state concentrations (right) of acid-forming and eutrophication S and N compounds. Figure 1. Flowchart for calculating critical loads (left) or steady-state concentrations (right) of acid-forming and eutrophication S and N compounds.
Fig. 9.2 Synthesis flowchart of modern carbon for essentially flat C3 compounds. Some of the steps (2,3 8,9) may be connected into a continuous process. The energy intensity of the steps is indicated by the coloring scheme. Fig. 9.2 Synthesis flowchart of modern carbon for essentially flat C3 compounds. Some of the steps (2,3 8,9) may be connected into a continuous process. The energy intensity of the steps is indicated by the coloring scheme.
Fig. 7.5 Schematic flowchart of the competitive MS-binding assay quantifying the nonbound marker employed for dopamine Di receptors. After incubation of the target (Di receptor) in presence of the marker (SCH 23390) and a test compound, the binding samples are centrifuged to separate bound from nonbound marker. The nonbound marker in the resulting supernatant is quantified by LC-ESI-MS/MS without further sample preparation. Fig. 7.5 Schematic flowchart of the competitive MS-binding assay quantifying the nonbound marker employed for dopamine Di receptors. After incubation of the target (Di receptor) in presence of the marker (SCH 23390) and a test compound, the binding samples are centrifuged to separate bound from nonbound marker. The nonbound marker in the resulting supernatant is quantified by LC-ESI-MS/MS without further sample preparation.
Fig. 7.15 Schematic flowchart of MS binding assays quantifying bound marker. Incubation of the target (mGATl) in presence of the marker (NO 711) and a test compound is conducted in a 96-well plate. The bound marker is separated from the nonbound marker by vacuum filtration. In the next step the target bound marker remaining on the filter is liberated with methanol. Finally, the liberated marker is quantified by LC-ESI-MS/MS. Fig. 7.15 Schematic flowchart of MS binding assays quantifying bound marker. Incubation of the target (mGATl) in presence of the marker (NO 711) and a test compound is conducted in a 96-well plate. The bound marker is separated from the nonbound marker by vacuum filtration. In the next step the target bound marker remaining on the filter is liberated with methanol. Finally, the liberated marker is quantified by LC-ESI-MS/MS.
Let us take the exposure packages as an example technically, most of these assays are highly automated, require small amount of compounds and have a brief cycle time. Scientifically, they fulfill requirements to predict exposure by addressing the three major contributing factors solubility, passive permeability and metabolic (hepatic) clearance. These type of packages are ideal to explore or diagnose scaffold characteristics and define project flowcharts. They can be used repeatedly to test newly synthesized compounds and guide SAR. A number of compounds within a... [Pg.48]

FLOWCHART TO DETERMINE A COMPOUND FORMULA WHEN GIVEN A NAME... [Pg.261]

FLOWCHART TO DETERMINE A COMPOUND NAME WHEN GIVEN A FORMULA... [Pg.262]

FIGURE 13.2 Flowchart of work for plant to extract through discovery studies to pure compounds with known structure and biological activities. [Pg.218]

As noted on several previous occasions, laomerB are compounds that havt the aame cbe/nical fonnulu but different alnictures. We ve seen aevenJJ kinds of isomers in the past few chapters, and it s a good idea at this point to see how they relate to orve another by looking at the flowchart in Figure 9.14,... [Pg.348]

The following flowchart is useful when you are naming binary ionic compounds ... [Pg.36]

This Chapter provides a brief historical overview of chemical nomenclature (Section IR-1.2) followed by summaries of its aims, functions and methods (Sections IR-1.3 to IR-1.5). There are several systems of nomenclature that can be applied to inorganic compounds, briefly described in Section IR-1.5.3.5 as an introduction to the later, more detailed, chapters. Because each system can provide a valid name for a compound, a flowchart is presented in Section IR-1.5.3 which should help identify which is the most appropriate for the type of compound of interest. Section IR-1.6 summarises the major changes from previous... [Pg.1]

The flowchart shown in Figure IR-1.1 (see page 9) proposes general guidelines for naming compounds and other species. [Pg.8]

The flowchart shown in Figure IR-9.1 illustrates a general procedure for producing a name for a coordination compound. Sections containing the detailed rules, guidelines and examples relevant to each stage of the procedure are indicated. [Pg.150]

However, a A H calculation usually predicts the C-reacted compound to be thermodynamically more stable than the Z-reacted compound (mainly because of the greater C-Z bond strength in the C-reacted product compared to the C=C in the Z-reacted). However, this does depend on the relative C-E vs. 0-E bond strength. It is important to determine which is the dominant effect, product formation based upon product thermodynamic stability or upon kinetic direction from HSAB theory. To do this we need to determine whether the reaction is under kinetic or thermodynamic control. Figure 9.1 gives a flowchart for the decision for a common ambident nucleophile, an enolate anion (Z equals oxygen). [Pg.255]

Flowchart to Determine a Compound Formula When Given a Name... [Pg.267]

Flowchart to Determine a Compound Name When Given a Formula... [Pg.267]

Fig. 4 Screen capture of the HighRes Biosolutions Cellario graphical user interface (GUI) showing the icon-driven sequence of steps and process paths for the assay, compound, and control plates. The written protocol corresponding to the GUI flowchart is shown on the right... Fig. 4 Screen capture of the HighRes Biosolutions Cellario graphical user interface (GUI) showing the icon-driven sequence of steps and process paths for the assay, compound, and control plates. The written protocol corresponding to the GUI flowchart is shown on the right...

See other pages where Flowcharts compounds is mentioned: [Pg.164]    [Pg.456]    [Pg.112]    [Pg.79]    [Pg.127]    [Pg.43]    [Pg.286]    [Pg.127]    [Pg.308]    [Pg.308]    [Pg.405]    [Pg.521]    [Pg.265]    [Pg.199]    [Pg.39]    [Pg.653]    [Pg.165]    [Pg.193]    [Pg.172]    [Pg.111]    [Pg.372]    [Pg.313]    [Pg.470]    [Pg.73]   
See also in sourсe #XX -- [ Pg.8 ]




SEARCH



Flowcharts

© 2024 chempedia.info